Weight Loss

Semaglutide

GLP-1 Receptor Agonist for Sustainable Fat Loss

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist originally developed for type 2 diabetes that has demonstrated remarkable efficacy for weight management. It works by mimicking the GLP-1 hormone, reducing appetite, slowing gastric emptying, and improving insulin sensitivity.

Key Benefits

  • Reduces appetite and caloric intake
  • Slows gastric emptying for satiety
  • Improves insulin sensitivity
  • Cardiovascular risk reduction
  • Sustainable long-term weight loss
  • Reduces visceral fat

Who It's For

  • Adults with BMI ≥ 27 with weight-related conditions
  • Those who have struggled with diet and exercise alone
  • Patients with type 2 diabetes seeking weight management
  • Anyone seeking physician-supervised weight loss

FAQs

How much weight can I expect to lose?

Clinical trials show an average of 15-20% body weight reduction over 68 weeks with lifestyle modifications.

How is it administered?

Semaglutide is administered via subcutaneous injection once weekly.

Are there side effects?

Common side effects include nausea, vomiting, and diarrhea, especially when starting. These typically subside as your body adjusts.